V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003555 | 10008102 | 1.64 | 63.1 | Curative (C) | 2017-10-01 | 2017-10-03 | Cisplatin + Radiotherapy + CISPLATIN | N | Y | 10482023 | CISPLATIN + RT |
| 10003556 | 10008102 | 1.66 | 81.8 | Neo-adjuvant (N) | null | 2015-02-26 | EC | N | N | 10482023 | ABIRATERONE |
| 10003557 | 10002257 | null | null | Disease modification (D) | 2018-03-16 | 2018-03-16 | Abiraterone | N | null | 10482124 | PACLITAXEL |
| 10003558 | 10002258 | null | null | Neo-adjuvant (N) | 2018-05-08 | 2018-05-14 | Capecitabine 35days + RT | null | N | 10482137 | CAPECITABINE + RT |
| 10003559 | 10002259 | 1.81 | 82.8 | Disease modification (D) | 2016-06-04 | 2016-06-20 | EC | N | N | 10482140 | CHOP |
| 10003560 | 10002260 | 1.77 | 90.4 | Palliative (P) | 2017-07-22 | 2017-07-23 | Capecitabine + Cisplatin | 02 | N | 10482169 | ABIRATERONE |
| 10003561 | 10002261 | 1.59 | 54.5 | Neo-adjuvant (N) | 2017-11-29 | 2017-12-01 | ABVD | 02 | null | 10482185 | ABVD |
| 10003562 | 10002262 | 1.76 | 67.7 | Curative (C) | 2018-06-24 | 2018-07-09 | Capecitabine 42days + RT | null | Y | 10482223 | CAPECITABINE + RT |
| 10003563 | 10002263 | 0 | 82.8 | null | 2016-08-20 | 2016-09-08 | ABVD | N | Y | 10482270 | ABVD |
| 10003564 | 10002264 | null | null | Adjuvant (A) | 2014-01-26 | 2014-03-24 | Fluorouricil + Folonic Acid (MdG) | Y | Y | 10482295 | FLUOROURACIL |
| 10003565 | 10002265 | 1.78 | 84 | Curative (C) | 2016-10-30 | 2016-11-24 | Cisplatin + Radiotherapy | N | Y | 10482327 | CISPLATIN + RT |
| 10003566 | 10002266 | 1.72 | 65 | Curative (C) | 2017-07-09 | 2017-07-20 | EC | N | N | 10482396 | CTD |
| 10003567 | 10002267 | 1.78 | 108 | Adjuvant (A) | 2018-03-15 | 2018-03-25 | FLUOROURACIL | 02 | N | 10482494 | FLUOROURACIL |
| 10003568 | 10002267 | 1.54 | 56 | Curative (C) | 2018-04-07 | 2018-04-19 | Capecitabine 35days + RT | 02 | N | 10482494 | CAPECITABINE + RT |
| 10003569 | 10008103 | 1.69 | 78.9 | Palliative (P) | 2018-09-22 | 2018-10-14 | Irinotecan + Modified De Gramont | 02 | N | 10482534 | IRINOTECAN + MDG |
| 10003570 | 10002268 | 1.8 | 81.5 | null | null | 2017-04-17 | Irinotecan + Modified De Gramont | N | Y | 10482674 | IRINOTECAN + MDG |
| 10003571 | 10002268 | null | 90 | Adjuvant (A) | 2016-04-28 | 2016-04-29 | Cisplatin 7 day | null | null | 10482674 | PACLITAXEL |
| 10003572 | 10002268 | 1.77 | 67 | Curative (C) | 2016-11-11 | 2016-12-02 | CISPLATIN + RT | null | N | 10482674 | CISPLATIN + RT |
| 10003573 | 10002269 | 1.6 | 67 | Neo-adjuvant (N) | 2018-10-25 | 2018-10-31 | Abiraterone | 2 | N | 10482824 | CAPECITABINE + CISPLATIN |
| 10003574 | 10002270 | 1.73 | 74 | Adjuvant (A) | 2013-10-27 | 2013-10-28 | FEC + DOCETAXEL | 02 | N | 10482879 | FEC + DOCETAXEL |
| 10003575 | 10002270 | 1.7 | 78.4 | Disease modification (D) | 2016-06-15 | 2016-06-23 | Cisplatin + Etoposide (3 day) | 2 | N | 10482879 | ABIRATERONE |
| 10003576 | 10002270 | 1.74 | 73.1 | Adjuvant (A) | 2015-10-29 | 2015-11-17 | Azacitidine | 02 | Y | 10482879 | AZACITIDINE |
| 10003577 | 10002271 | 1.81 | null | Disease modification (D) | 2018-07-06 | 2018-07-19 | CTD | N | N | 10482935 | BORTEZOMIB |
| 10003578 | 10002272 | 1.78 | null | Curative (C) | 2014-06-26 | 2014-07-01 | Chlorambucil | N | N | 10482982 | FLUOROURACIL + MITOMYCIN + RT |
| 10003579 | 10002272 | 1.66 | 68 | Palliative (P) | null | 2018-09-23 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10482982 | CTD |
| 10003580 | 10002272 | 1.58 | 62.3 | Disease modification (D) | null | 2016-12-08 | Gemcitabine + Capecitabine | N | N | 10482982 | CHLORAMBUCIL |
| 10003581 | 10008808 | 1.81 | 90.3 | Palliative (P) | 2015-07-26 | 2015-07-26 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10483096 | FLUOROURACIL + MITOMYCIN + RT |
| 10003582 | 10002273 | 1.65 | null | Palliative (P) | 2016-10-30 | 2016-11-08 | Bortezomib + Cyclophos + Dex | 2 | N | 10483106 | CHOP |
| 10003583 | 10002273 | 1.71 | 67 | Curative (C) | 2017-02-12 | 2017-02-13 | Abiraterone | N | null | 10483106 | FLUOROURACIL + MITOMYCIN + RT |
| 10003584 | 10002274 | 1.78 | 95 | Palliative (P) | 2016-09-07 | 2016-09-07 | BCG Intravesical | 02 | N | 10483123 | CAPECITABINE + GEMCITABINE |
| 10003585 | 10002275 | 1.7 | 64.9 | Palliative (P) | null | 2017-09-17 | BCG Intravesical | N | N | 10483238 | CTD |
| 10003586 | 10002276 | 1.77 | 60 | Adjuvant (A) | 2017-06-26 | 2017-06-26 | FEC + DOCETAXEL | 99 | N | 10483298 | FEC + DOCETAXEL |
| 10003587 | 10002277 | 1.64 | 49.9 | Curative (C) | 2015-12-05 | 2015-12-15 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10483336 | EC |
| 10003588 | 10002278 | 1.46 | 79.6 | Curative (C) | 2017-10-30 | 2017-11-05 | Abiraterone | 2 | N | 10483364 | CTD |
| 10003589 | 10002278 | 1.57 | 69.5 | Curative (C) | 2017-06-06 | 2017-06-06 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10483364 | CISPLATIN + ETOPOSIDE |
| 10003590 | 10002279 | null | 0 | Curative (C) | 2014-12-09 | 2014-12-18 | Imatinib 400mg | N | N | 10483430 | CISPLATIN + ETOPOSIDE |
| 10003591 | 10002280 | 1.84 | null | Adjuvant (A) | 2015-04-30 | 2015-05-03 | Temozolomide + RT | N | N | 10483505 | BCG |
| 10003592 | 10002281 | 1.79 | 75.9 | Neo-adjuvant (N) | 2017-05-24 | 2017-06-15 | Capecitabine 35days + RT | N | Y | 10483528 | CAPECITABINE + RT |
| 10003593 | 10002281 | 1.67 | 68 | Curative (C) | 2018-05-20 | 2018-05-20 | FEC 100 + DOCETAXEL | 2 | N | 10483528 | FEC + DOCETAXEL |
| 10003594 | 10002281 | 1.65 | 54.8 | Adjuvant (A) | 2016-05-29 | 2016-06-08 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10483528 | ABVD |
| 10003595 | 10002282 | 1.75 | 113 | Palliative (P) | 2014-07-06 | 2014-07-20 | Gemcitabine + Capecitabine | N | N | 10483625 | BORTEZOMIB |
| 10003596 | 10002283 | 1.81 | 85 | Palliative (P) | 2014-12-18 | 2014-12-20 | CAPECITABINE + GEMCITABINE | 2 | N | 10483645 | PACLITAXEL |
| 10003597 | 10006462 | 1.83 | null | Disease modification (D) | 2013-08-04 | 2013-08-18 | Capecitabine + Cisplatin | 02 | N | 10483677 | TEMOZOLOMIDE + RT |
| 10003598 | 10006462 | null | null | Palliative (P) | 2019-02-02 | 2019-02-05 | CVD | N | N | 10483677 | BORTEZOMIB |
| 10003599 | 10002284 | 1.62 | 73.9 | Curative (C) | 2018-10-30 | 2018-11-09 | Cisplatin | N | N | 10483709 | CAPECITABINE + CISPLATIN |
| 10003600 | 10002284 | null | 70.5 | Adjuvant (A) | 2017-12-04 | 2017-12-07 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10483709 | FLUOROURACIL |
| 10003601 | 10002285 | 1.8 | 91 | Palliative (P) | 2018-01-02 | 2018-02-01 | CTD | 2 | N | 10483838 | FLUOROURACIL + MITOMYCIN + RT |
| 10003602 | 10002286 | null | 55.8 | Palliative (P) | 2017-08-08 | 2017-08-23 | FLUOROURACIL + FOLINIC ACID | N | N | 10483846 | FLUOROURACIL |
| 10003603 | 10002286 | 1.74 | 66.35 | Adjuvant (A) | 2016-11-15 | 2016-11-15 | Capecitabine + Cisplatin | 02 | null | 10483846 | AZACITIDINE |
| 10003604 | 10002286 | 1.65 | 71 | Palliative (P) | 2016-06-04 | 2016-06-23 | Irinotecan + Modified De Gramont | N | N | 10483846 | IRINOTECAN + MDG |